These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats. Vige X, Briley M. Neurosci Lett; 1988 Jun 07; 88(3):319-24. PubMed ID: 3386878 [Abstract] [Full Text] [Related]
4. Recovery of neocortical choline acetyltransferase activity following ibotenic acid injection into the nucleus basalis of Meynert in rats. Wenk GL, Olton DS. Brain Res; 1984 Feb 13; 293(1):184-6. PubMed ID: 6704718 [Abstract] [Full Text] [Related]
6. Effect of prolonged co-dergocrine mesylate treatment on choline acetyltransferase levels in rat cerebral cortex after lesioning of the nucleus basalis magnocellularis (of Meynert). Amenta D, De Rossi M, Amenta F. Pharmacol Res Commun; 1988 Sep 13; 20(9):799-810. PubMed ID: 3174805 [Abstract] [Full Text] [Related]
7. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Mishkin M. Psychopharmacology (Berl); 1987 Sep 13; 92(3):292-300. PubMed ID: 3114781 [Abstract] [Full Text] [Related]
8. Effects of nBM lesions on muscarinic-stimulation of phosphoinositide hydrolysis. Raulli RE, Arendash G, Crews FT. Neurobiol Aging; 1989 Sep 13; 10(2):191-7. PubMed ID: 2542819 [Abstract] [Full Text] [Related]
9. Are the neurochemical and behavioral changes induced by lesions of the nucleus basalis in the rat a model of Alzheimer's disease? Pepeu G, Casamenti F, Pedata F, Cosi C, Pepeu IM. Prog Neuropsychopharmacol Biol Psychiatry; 1986 Sep 13; 10(3-5):541-51. PubMed ID: 2879319 [Abstract] [Full Text] [Related]
10. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. J Neurochem; 1988 Jun 13; 50(6):1914-23. PubMed ID: 3373218 [Abstract] [Full Text] [Related]
12. Further characterizations of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the rat. Altman HJ, Crosland RD, Jenden DJ, Berman RF. Neurobiol Aging; 1985 Jun 13; 6(2):125-30. PubMed ID: 4022231 [Abstract] [Full Text] [Related]
13. A subcortico-cortical cholinergic system is affected in Parkinson's disease. Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y. Brain Res; 1983 Dec 12; 288(1-2):213-8. PubMed ID: 6661617 [Abstract] [Full Text] [Related]
14. Effects of scopolamine treatment and lesion of the nucleus basalis upon various cholinergic markers in the rat brain cortex. Moret C, Pastrie I, Briley M. Neurochem Int; 1989 Dec 12; 15(3):333-7. PubMed ID: 20504503 [Abstract] [Full Text] [Related]
15. Effects of nucleus basalis lesions on the muscarinic and nicotinic modulation of [3H]acetylcholine release in the rat cerebral cortex. Meyer EM, Arendash GW, Judkins JH, Ying L, Wade C, Kem WR. J Neurochem; 1987 Dec 12; 49(6):1758-62. PubMed ID: 3681294 [Abstract] [Full Text] [Related]
16. A glutamatergic innervation of the nucleus basalis/substantia innominata. Davies SW, McBean GJ, Roberts PJ. Neurosci Lett; 1984 Mar 09; 45(1):105-10. PubMed ID: 6328369 [Abstract] [Full Text] [Related]